![]() Lucira Health Lucira Health (formerly known as Diassess) is a company that develops infectious disease tests. | Surfacide Surfacide is a company that designs and manufactures ultraviolet (UV) disinfectant devices. | ![]() Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. | ![]() CellaVision CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector. | ![]() Biolinq Biolinq develops skin-applied electronic sensors that analyze body fluids to provide health information. | |
Founding Date | Founding Date 2013 | Founding Date 2010 | Founding Date 1997 | Founding Date 1994 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Emeryville, US HQ | Locations Waukesha, US HQ | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US | Locations San Diego, US HQ | |
Employees | Employees 274% decrease | Employees 363% decrease | Employees 4235% increase | Employees 228 | Employees 1022% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 9.3 m | Valuation ($) 551.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $93.1m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $24m (FY, 2025) | Revenue (est.) kr759m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $81.4m (FY, 2021) | Cost of goods N/A | Cost of goods $13.3m (FY, 2025) | Cost of goods kr224.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $10.2m (FY, 2021) | Gross profit N/A | Gross profit $10.7m (FY, 2025) | Gross profit kr534.2m (FY, 2025) | Gross profit N/A |
Net income | Net income ($64.8m) (FY, 2021) | Net income N/A | Net income ($363k) (FY, 2025) | Net income kr153.1m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 69.5m | Total funding raised N/A | Total funding raised $ 1.5m | Total funding raised N/A | Total funding raised $ 14.8m |
Surfacide is a company that designs and manufactures ultraviolet (UV) disinfectant devices.
View company
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
View company
CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector.
View company
Biolinq develops skin-applied electronic sensors that analyze body fluids to provide health information.
View company